Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Achieving Active Surveillance for Thyroid Cancer—Not a Euphemism for Watching a Ticking Time Bomb

Achieving Active Surveillance for Thyroid Cancer—Not a Euphemism for Watching a Ticking Time Bomb Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers Original Investigation Research Invited Commentary Achieving Active Surveillance for Thyroid Cancer— Not a Euphemism for Watching a Ticking Time Bomb Joseph Scharpf, MD Thyroid cancer has been recognized as the most rapidly in- ously studied 1.0-cm cutoff to allow for active surveillance creasing cancer in the United States, tripling in incidence over in select patients with 1.0- to 1.5-cm tumors, and this group the past 3 decades. It is estimated that there will be 56 870 new also showed a low probability for growth. Finally, a small cases in the United States (42 470 in women and 14 400 in men) percentage of patients was reported to experience tumor regression. in 2017. The mortality from thyroid cancer has remained This study provides invaluable and much-needed sup- Related article page 1015 stable and low, with 2010 port to implement active surveillance protocols in the United 1 4 deaths estimated this year. States. The authors acknowledged that the success of their Increased diagnostic testing, particularly with ultrasonogra- active surveillance management program requires a highly spe- phy, has been responsible for much of this rise in incidence. cialized and skilled multidisciplinary team http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology - Head & Neck Surgery American Medical Association

Achieving Active Surveillance for Thyroid Cancer—Not a Euphemism for Watching a Ticking Time Bomb

JAMA Otolaryngology - Head & Neck Surgery , Volume 143 (10) – Oct 31, 2017

Loading next page...
 
/lp/american-medical-association/achieving-active-surveillance-for-thyroid-cancer-not-a-euphemism-for-JnSaEqt5xs

References (7)

Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/jamaoto.2017.1453
Publisher site
See Article on Publisher Site

Abstract

Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers Original Investigation Research Invited Commentary Achieving Active Surveillance for Thyroid Cancer— Not a Euphemism for Watching a Ticking Time Bomb Joseph Scharpf, MD Thyroid cancer has been recognized as the most rapidly in- ously studied 1.0-cm cutoff to allow for active surveillance creasing cancer in the United States, tripling in incidence over in select patients with 1.0- to 1.5-cm tumors, and this group the past 3 decades. It is estimated that there will be 56 870 new also showed a low probability for growth. Finally, a small cases in the United States (42 470 in women and 14 400 in men) percentage of patients was reported to experience tumor regression. in 2017. The mortality from thyroid cancer has remained This study provides invaluable and much-needed sup- Related article page 1015 stable and low, with 2010 port to implement active surveillance protocols in the United 1 4 deaths estimated this year. States. The authors acknowledged that the success of their Increased diagnostic testing, particularly with ultrasonogra- active surveillance management program requires a highly spe- phy, has been responsible for much of this rise in incidence. cialized and skilled multidisciplinary team

Journal

JAMA Otolaryngology - Head & Neck SurgeryAmerican Medical Association

Published: Oct 31, 2017

There are no references for this article.